Company intelligence / Profile preview

Biomax Informatics

Planegg-Martinsried, Bavaria, Germany

Ownership: Private
Employees: ~45
Development stage: Other

Overview

Biomax Informatics does not develop clinical therapeutics; instead, it provides modular bioinformatics platforms and AI-powered semantic technologies to accelerate knowledge-driven research and clinical decision-making in life sciences and healthcare sectors[1][2][3][4][5][6].

Industry: Drug Discovery Services

Partnerships

LabVantage Solutions (merger, 2023)[4]Academic collaborations with European universities for connectome/neuroimaging research[4]

Beyond the preview

Go deeper on Biomax Informatics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomax Informatics.

Explore the full profile